Case Study: Reducing Adverse Drug Events Through Better Reporting and Analysis

Author：

ISSN： 1534-5181

Source： Joint Commission Perspectives on Patient Safety, Vol.4, Iss.2, 2004-02, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medication Station: Reducing Anticoagulation-Related Adverse Drug Events: Closely monitoring and managing risks for patients on warfarin

Joint Commission Perspectives on Patient Safety, Vol. 6, Iss. 7, 2006-07 ,pp. : 3-4

Joint Commission Resources

Access to resources Recommend Favorite

Benefits of Pharmacogenomics in Drug Development—Earlier Launch of Drugs and Less Adverse Events

By Ohashi Wataru Tanaka Hiroshi

Journal of Medical Systems, Vol. 34, Iss. 4, 2010-08 ,pp. : 701-707

Springer Publishing Company

Access to resources Recommend Favorite

Actionable Error Reporting Systems: Learning from—rather than just documenting—preventable adverse events

Joint Commission Perspectives on Patient Safety, Vol. 5, Iss. 11, 2005-11 ,pp. : 5-7

Joint Commission Resources

Access to resources Recommend Favorite

Apply Influence Diagrams for Utility Analysis of Paying the Weight-Reducing Expenses: A Case Study in Taiwan

By Wu Fan Sun Pei-Ran Chang Chi-Chang

Journal of Medical Systems, Vol. 35, Iss. 1, 2011-02 ,pp. : 105-111

Springer Publishing Company

Access to resources Recommend Favorite

Cognitive Aspects of Adverse Events

By Redman Richard W.

Scholarly Inquiry for Nursing Practice, Vol. 21, Iss. 1, 2007-03 ,pp. : 10-12

Springer Publishing Company

Access to resources Recommend Favorite